Recombinant Human ATF2 Protein，His

ATF2, or Activating Transcription Factor 2, is a member of the basic region-leucine zipper (bZIP) family of transcription factors and plays a crucial role in the regulation of gene expression in response to various stress signals, such as UV radiation and oxidative stress. Its function is essential for cellular stress response, differentiation, and apoptosis. Research has shown that ATF2 is involved in numerous biological processes, including cell cycle regulation and apoptosis, making it a critical target for understanding cancer biology and therapy. The dysregulation of ATF2 has been implicated in several cancers, as it can function as both a tumor suppressor and an oncogene, depending on the cellular context. Given its dual role in tumorigenesis, investigating the structure, function, and interaction of ATF2 through recombinant protein studies is crucial. The expression and purification of recombinant ATF2 proteins allow for detailed biochemical characterization and structural analysis, providing insights into its regulatory mechanisms and potential as a therapeutic target. Furthermore, studying the post-translational modifications and protein interactions of ATF2 in various cellular environments can unveil its complex role in cancer progression and therapeutic resistance, thereby contributing to the development of targeted cancer therapies. Thus, ATF2 recombinant protein research is not only vital for understanding fundamental cellular processes but also holds promise for informing novel treatment strategies in oncology.